SAM
Sectoral Asset Management’s Arcus Biosciences RCUS Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.09M | Buy |
257,270
+230,400
| +857% | +$1.88M | 1.38% | 18 |
|
|
2025
Q1 | $211K | Sell |
26,870
-42,682
| -61% | -$335K | 0.16% | 70 |
|
|
2024
Q4 | $1.04M | Sell |
69,552
-5,970
| -8% | -$88.9K | 0.69% | 40 |
|
|
2024
Q3 | $1.15M | Sell |
75,522
-2,863
| -4% | -$43.8K | 0.68% | 46 |
|
|
2024
Q2 | $1.19M | Sell |
78,385
-15,250
| -16% | -$232K | 0.49% | 53 |
|
|
2024
Q1 | $1.77M | Sell |
93,635
-3,800
| -4% | -$71.7K | 0.7% | 46 |
|
|
2023
Q4 | $1.86M | Sell |
97,435
-278,021
| -74% | -$5.31M | 0.8% | 50 |
|
|
2023
Q3 | $6.74M | Buy |
375,456
+20,966
| +6% | +$376K | 1.31% | 26 |
|
|
2023
Q2 | $7.2M | Buy |
354,490
+60,844
| +21% | +$1.24M | 1.2% | 33 |
|
|
2023
Q1 | $5.36M | Buy |
293,646
+55,164
| +23% | +$1.01M | 1.03% | 41 |
|
|
2022
Q4 | $4.93M | Buy |
238,482
+11,450
| +5% | +$237K | 0.95% | 47 |
|
|
2022
Q3 | $5.94M | Sell |
227,032
-84,750
| -27% | -$2.22M | 1.17% | 32 |
|
|
2022
Q2 | $7.9M | Sell |
311,782
-26,698
| -8% | -$677K | 1.59% | 20 |
|
|
2022
Q1 | $10.7M | Buy |
338,480
+55,270
| +20% | +$1.74M | 1.9% | 15 |
|
|
2021
Q4 | $11.5M | Sell |
283,210
-455,800
| -62% | -$18.4M | 1.73% | 17 |
|
|
2021
Q3 | $25.8M | Buy |
739,010
+64,750
| +10% | +$2.26M | 2.14% | 4 |
|
|
2021
Q2 | $18.5M | Sell |
674,260
-184,950
| -22% | -$5.08M | 1.5% | 23 |
|
|
2021
Q1 | $24.1M | Sell |
859,210
-1,950
| -0.2% | -$54.8K | 1.83% | 14 |
|
|
2020
Q4 | $22.4M | Sell |
861,160
-61,640
| -7% | -$1.6M | 1.58% | 27 |
|
|
2020
Q3 | $15.8M | Buy |
+922,800
| New | +$15.8M | 1.36% | 30 |
|
|
2020
Q2 | – | Sell |
-261,213
| Closed | -$3.63M | – | 195 |
|
|
2020
Q1 | $3.63M | Buy |
+261,213
| New | +$3.63M | 0.7% | 54 |
|